# Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.

Study · id `cardio:ct-nct07048808` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07048808](<https://clinicaltrials.gov/study/NCT07048808>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07048808

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 106 participants.

## Technical summary

Registry record NCT07048808. Randomized; quadruple masking; primary purpose treatment. Start 2025-07-08 (actual); primary completion 2027-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 106 participants (planned count; ClinicalTrials.gov record NCT07048808, source copy `cardio:ctgov-nct07048808-2026-09-11`, retrieved 2026-10-26)
- Started: 2025-07-08 (actual) (ClinicalTrials.gov record NCT07048808, source copy `cardio:ctgov-nct07048808-2026-09-11`, retrieved 2026-10-26)
- Primary completion: 2027-06-30 (anticipated) (ClinicalTrials.gov record NCT07048808, source copy `cardio:ctgov-nct07048808-2026-09-11`, retrieved 2026-10-26)
- Completion: 2027-12-30 (anticipated) (ClinicalTrials.gov record NCT07048808, source copy `cardio:ctgov-nct07048808-2026-09-11`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT07048808, source copy `cardio:ctgov-nct07048808-2026-09-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07048808-2026-09-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
- Acronym: EXACT2
- Condition: Refractory Angina
- Condition: Coronary Artery Disease
- Intervention (Combination product): XC001
- Intervention (Combination product): Sham (No Treatment)
- Lead sponsor: XyloCor Therapeutics, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

## Provenance

Content hash: afc3407db2829d55951461556359ba52201f41675ff300b92c742dcf56cc8f5e
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
